parkinson's disease

272 Ali Wolf, fama PR M - Files@famapr.com Articoli correlati Rune Labs Applauds the Signing of the National Plan to End Parkinson's Disease Business Wire Business Wire - 3 Luglio 2024 SAN FRANCISCO -...

SAN FRANCISCO-(BUSINESS WIRE)- Rune Labs , a leader in precision medicine for Parkinson's disease, celebrates the signing of the National Plan to End Parkinson's Disease into law. This landmark legislation aims to unite federal and philanthropic efforts to diagnose and treat ...

Contacts Jonathan Karush - press@accessadvance.com Articoli correlati Rune Labs Applauds the Signing of the National Plan to End Parkinson's Disease Business Wire Business Wire - 3 Luglio 2024 SAN ...

Domingo Director of Investor Relations, SLB Tel: +1 (713) 375 - 3535 investor - relations@slb.com Articoli correlati Rune Labs Applauds the Signing of the National Plan to End Parkinson's Disease ...

Continua a leggere Parkinson's Disease: A Digital Biomarker Platform for Differentiated Diagnosis Business Wire Business Wire - 2 Luglio 2024  BrainTale was attending the 10th Congress of the ...

... co - founder and scientific director, and Martin Grange, data scientist , demonstrated the potential of BrainTale's solution to specifically differentiate Parkinson's disease (PD) from other ...

Continua a leggere Parkinson's Disease: A Digital Biomarker Platform for Differentiated Diagnosis Business Wire Business Wire - 2 Luglio 2024  BrainTale was attending the 10th Congress of the ...

Continua a leggere Parkinson's Disease: A Digital Biomarker Platform for Differentiated Diagnosis Business Wire Business Wire - 2 Luglio 2024  BrainTale was attending the 10th Congress of the ...

Il nuovo studio condotto da scienziati della Nagoya University Graduate School of Medicine in Giappone, pubblicato sulla rivista npj Parkinson's Disease , ha esaminato il microbiota di persone con e ...

Benefits of tango therapy in alleviating the motor and non - motor symptoms of Parkinson's disease patients—a narrative review. Brain Sciences, 12(4), 448. Rabini, G., Meli, C., Prodomi, G. et al. ...